Evaluation of CD44 Variant Expression in Oral,Head and Neck Squamous Cell Carcinomas Using a Triple Approach and its Clinical Significance

Abstract

Cancer stem cells possess the qualities of self-renewal, tumorigenesis and the ability to recapitulate a heterogeneous tumor. Our group was the first to isolate head and neck squamous cell carcinoma (HNSCC) stem cells using the cell surface marker CD44. CD44 is a trans-membrane glycoprotein with a multitude of key-functions that regulate cancer cell proliferation and metastasis. The variety of CD44 functions is due to tissue-specific patterns of glycosylation of the extracellular portion, and to the multiple protein isoforms (CD44 variants, CD44v) generated by alternative splicing. This study investigates the expression pattern of CD44 variants in HNSCC. Ten cell lines from the most common HNSCC locations and representative of various clinical outcomes were assayed by quantitative real-time PCR, flow cytometry and immunofluorescence comparatively with normal oral keratinocytes. The CD44 v4 and v6 were exclusively abundant in HNSCC while the isoform v1,2 was expressed in normal oral keratinocytes. Of interest, the highest level of CD44v6 expression was detected in advanced metastatic HNSCC, suggesting a link between CD44v6 expression and HNSCC metastasis, while the highest CD44v4 was detected in a stage IV HNSCC refractory to chemotherapy which developed recurrence. Oral-derived HNSCC expressed the highest CD44v4 and v6, and levels corresponded with staging, showing also an increasing tendency with recurrence and metastasis. CD44v were detected predominantly in smaller cells (a characteristic that has been associated with stem cell properties) or cells with mesenchymal morphology (a characteristic that has been associated with the migratory and invasive potential of epithelial tumor cells), suggesting that CD44v differential expression in HNSCC may be representative of the morphological changes inherent during tumor progression towards a more aggressive potential, and thus contributing to the individual tumor biology. The mechanism of CD44 variant involvement in HNSCC progression and metastasis is under investigation.

Keywords

head and neck squamous carcinoma (HNSCC)cell lines CD44 variants cancer stem cells clinical outcome metastasis

References

Prince

Sivanandan

Kaczorowski

. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104:973–78.

Shah

Johnson

Batsakis

. Complications and their management. In: Singh

Shah

, editors. Oral cancer. 1st ed. London: Martin Dunitz, 2003; p. 367–72.

Davis

Divi

Owen

Bradford

Carey

Papagerakis

Prince

. Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2010; 136:1260–66.

Krishnamurthy

Dong

Vodopyanov

Imai

Helman

Prince

Wicha

Nor

. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res 2010; 70:9969–78.

Mannelli

Gallo

. Cancer stem cells hypothesis and stem cells in head and neck cancers. Cancer Treat Rev 2012; 38:515–39.

Hofmann

Rudy

Zoller

Tolg

Ponta

Herrlich

Gunthert

. CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 1991;51:5292–97.

Arch

Wirth

Hofmann

Ponta

Matzku

Herrlich

Zoller

. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992; 257:682–85.

Gunthert

Schwarzler

Witting

. Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis. Adv Exp Med Biol 1998;451:43–49.

Levesque

Haynes

. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma. J Immunol 2001; 166:188–96.

10.

Rosemblatt

Bono

. Functional consequences of immune cell adhesion to endothelial cells. Curr Pharm Des 2004; 10:109–20.

11.

Marhaba

Zoller

. CD44 in cancer progression: Adhesion, migration and growth regulation. J Mol Histol 2004; 35:211–31.

12.

Barbour

Reeder

Walsh

Fawcett

Antalis

Gotley

. Expression of the CD44v2–10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Res 2003; 63:887–92.

13.

Seiter

Arch

Reber

Komitowski

Ponta

Herrlich

Matzku

Zoller

. Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177:443–55.

14.

Wittig

Seiter

Foger

Schwarzler

Gunthert

Zoller

. Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity. Immunol Lett 1997; 57:217–23.

15.

Chu

Weiss

. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40:403–39.

16.

Goldman

Blundell

Lopes

Kinnon

Di Santo

Thrasher

. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 1998; 103:335–42.

17.

Massengale

Wagers

Vogel

Weissman

. Hematopoietic cells maintain hematopoietic fates upon entering the brain. J Exp Med 2005; 201:1579–89.

18.

Molofsky

Bydon

Morrison

Pardal

. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005; 19:1432–37.

19.

Prochazka

Gaskins

Shultz

Leiter

. The non-obese diabetic SCID mouse: Model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A 1992; 89:3290–94.

20.

Wagers

Christensen

Weissman

. Cell fate determination from stem cells. Gene Ther 2002; 9:606–12.

21.

Franzmann

Reatequi

Pedroso

. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:1348–55.

22.

Carey

. Head and neck cancers. Human Cell Culture Vol II. Masters

JRW

Palsson

(Eds.) Kluwer Academic Publishers 1999; p:185–255.

23.

Lin

Grandis

Carey

Gollin

Whiteside

Koch

Ferris

Lai

. Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection. Head Neck 2007; 29:163–88.

24.

Izumi

Tobita

Feinberg

. Isolation of human oral keratinocyte progenitor/stem cells. J Dent Res 2007; 86:341–46.

25.

Fox

Fawcett

Jackson

. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994; 54:4539–46.

26.

Ailles

Prince

. Cancer stem cells in head and neck squamous cell carcinoma. Methods Mol Biol 2009;568:175–93.

27.

Joshua

Kaplan

Doweck

Pai

Weissman

Prince

Ailles

. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: Correlation with tumor aggressiveness. Head Neck 2012; 34:42–49.

28.

Locke

Heywood

Fawell

Mackenzie

. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 2005; 65:8944–50.

29.

Nelson

Grandis

. The role of CD44 in HNSCC. Cancer Biol Ther 2007; 6:125–26.

30.

Papagerakis

Pannone

. Epithelial-mesenchymal interactions in oral cancer metastasis. Oral Cancer K. U. Ogbureke, Tech 2012; p:373–88.

31.

Misra

Heldin

Hascall

Karamanos

Skandalis

Markwald

Ghatak

. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J 2011; 278:1429–43.